Operates a hospital in Bharuch, Gujarat, providing healthcare services to patients. The Bharuch facility's bed capacity has doubled following a Permanent Clinical Establishment registration, taking total bed capacity from 40 to 65. Revenue from operations for FY26 reached Rs 599.47 lakhs, up from Rs 322.52 lakhs in FY25. The company is listed on the BSE SME platform and is deploying its IPO proceeds to purchase medical equipment and build a medical tourism portal. A Cath Lab Machine is being procured through a related-party arrangement (with the Managing Director's Heart Hospital) to meet Gujarat government empanelment norms under the AB PMJAY scheme for cardiology services. On the cost side, "other operating expenses" form the largest cost line at 45.5% of revenue, with employee costs at 19.3% and materials at 3.1%; capex was 54.7% of revenue in FY26, reflecting the ongoing capacity build-out. AR · MarketPing reader · 2026-08-02
Revenue streams, as the annual report describes them. Hospital and healthcare services. Small-cap, single-location hospital operator; recently IPO'd on BSE SME; in active capacity expansion phase
| ₹ crore · consolidated | FY25 | FY26 |
|---|---|---|
| Revenue | 3 | 6 |
| EBITDA (ex other income) | — | — |
| margin % | — | — |
| Owners' profit | — | — |
| EPS, as reported (₹) | 0.98 | 0.14 |
| ROE % · ROCE % | — · 7.9 | — · 2.6 |
| Debt / equity (x) | — | — |
| Cash from operations | (1) | 1 |
| Capex | (0) | (3) |
| ₹ crore | Q2 FY25 | Q4 FY25 | Q2 FY26 | Q4 FY26 |
|---|---|---|---|---|
| Revenue | 2 | 1 | 3 | 3 |
| Profit before tax | 1 | 0 | 0 | (0) |
| Net profit | — | — | — | — |
| EPS (₹) | 1.70 | 0.17 | 1.03 | 0.37 |
| Company | M.cap ₹ cr | P/E | P/B | EV/EBITDA | ROE % | ROCE % | Rev CAGR 5y % | EBITDA m. % |
|---|---|---|---|---|---|---|---|---|
| APOLLO HOSPITALS ENTER. L | 1,27,062 | 60.8 | 12.74 | 33.5 | 20.1 | 16.6 | 19.0 | 16.2 |
| MAX HEALTHCARE INS LTD | 1,00,993 | 69.2 | 9.40 | 44.0 | 13.4 | 11.1 | 27.3 | 27.0 |
| FORTIS HEALTHCARE LTD | 67,025 | 64.0 | 6.59 | 32.9 | 10.5 | 9.7 | 17.8 | 22.0 |
| ASTER DM QUALITY CARE LTD | 39,689 | 124.0 | 8.21 | 40.4 | 8.8 | 8.5 | (11.6) | 14.3 |
| GLOBAL HEALTH LIMITED | 38,972 | 70.0 | 9.78 | 39.4 | 13.9 | 13.5 | — | 23.7 |
| NARAYANA HRUDAYALAYA LTD. | 38,213 | 46.5 | 8.42 | 25.4 | 17.8 | 9.2 | 25.0 | 18.8 |
| Date · filing | Category | Importance | 1-day % | 5-day % |
|---|---|---|---|---|
| 11 Sept 2026 · CFO of Broach Lifecare resigns; company clarifies BSE query on disclosure | management changes | high | — | — |
| 9 Sept 2026 · AGM notice and annual report link sent to shareholders without registered email | compliance | minimal | — | — |
| 9 Sept 2026 · Newspaper publication notice for 3rd Annual General Meeting | compliance | minimal | — | — |
| 8 Sept 2026 · Annual Report FY2025-26 and 3rd AGM notice filed with BSE | results | medium | — | — |
| 8 Sept 2026 · Notice of 3rd AGM on September 30, 2026 with e-voting facility | board shareholder meetings | low | — | — |
| 5 Sept 2026 · Board appoints secretarial auditor, fixes AGM date for Sep 30 | management changes | low | — | — |
| 5 Sept 2026 · Board approves FY26 Directors Report, sets AGM for Sept 30, 2026 | management changes | medium | — | — |
| 31 Aug 2026 · Board Meeting on Sept 5 to approve Board's Report and AGM notice | board shareholder meetings | low | — | — |
| 31 Aug 2026 · Board meeting on Sept 5 to approve Board's Report and AGM notice | board shareholder meetings | low | — | — |
| 31 Aug 2026 · Company Secretary Ms Swati Sharma resigns effective 30 Aug 2026 | management changes | medium | — | — |
| Where a broker report shows | This document shows | Why |
|---|---|---|
| A rating (BUY / ADD / REDUCE / SELL) |
| KRISHNA INST OF MED SCI L |
| 32,235 |
| 150.5 |
| 12.60 |
| 43.4 |
| 9.5 |
| 5.1 |
| 24.0 |
| 20.3 |
| DR AGARWALS HEALTH CARE L | 16,043 | 107.9 | 7.57 | 26.2 | 7.9 | 7.1 | — | 28.8 |
| Metric | Company | Group median | Rank | Better than |
|---|---|---|---|---|
| P/E (TTM) | 4.5 | 47.3 | 2 of 30 | 97% |
| ROCE | 2.2 | 10.9 | 26 of 30 | 14% |
| Market cap | 9 | 2415 | 30 of 30 | 0% |
| A state: the latest filed quarter and the measured reactions |
| an event is a fact; a rating is an opinion that requires SEBI RA registration |
| A target price and upside | The current price and the multiples against the group | a target is a forecast; a multiple is a measurement |
| Estimate years marked E | More audited years; no estimates | MarketPing publishes no forecasts — your own model lives on the Models page |
This document is a statistical summary of publicly filed information and market data, prepared by software from primary sources: SEBI results XBRL filed with BSE and NSE, LODR disclosures, shareholding patterns, exchange price data. It contains no research recommendation, no price target and no opinion on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Financial statements are as filed (consolidated where the company files consolidated results). Ratios are computed over filed lines. Where a figure is unavailable the table shows a dash rather than an estimate. The business brief is written by MarketPing's reader from the annual report and checked against it; no figure in a table was generated by a model. Nothing here constitutes investment advice, an offer or a solicitation; readers should consult a SEBI-registered adviser before acting. MarketPing is not a SEBI-registered intermediary.
